MedPath

Solventum Pioneers Novel Tooth-Based Randomization Approach in Dental Clinical Trials Using Zelta Platform

  • Solventum has developed an innovative clinical trial methodology where individual teeth are enrolled as subjects, allowing multiple teeth from the same participant to be studied over time.

  • The company leveraged Zelta by Merative's cloud-based eClinical platform to implement a unique randomization model that pairs teeth of similar sizes, significantly reducing selection bias.

  • This novel approach, combined with Zelta's flexible Electronic Data Capture system, has substantially decreased trial build timelines and improved data entry efficiency for Solventum's dental studies.

In a groundbreaking development for dental clinical research, medical device company Solventum has implemented an innovative approach to clinical trial randomization by treating individual teeth as study subjects, utilizing Zelta by Merative's cloud-based eClinical platform.

Novel Trial Design Methodology

The revolutionary approach allows for the enrollment of individual teeth as study subjects, with participants able to contribute up to five teeth over multiple visits. This unique design addresses specific challenges in dental research while maintaining rigorous scientific standards. The methodology includes a sophisticated randomization model that pairs teeth of similar sizes, effectively reducing selection bias in the study.

Streamlined Data Management Process

Krista Dahling, Supervisor of Clinical Data Management for Solventum, emphasized the importance of efficiency in their fast-moving in-house clinical studies. "Our in-house clinical studies move very fast," she explained. "These studies are testing new concepts from the development team and they want answers fast. So, we are continually looking for new efficiencies in our trials."
The implementation leverages Zelta's Electronic Data Capture (EDC) platform capabilities to:
  • Link teeth to specific subject IDs, preventing duplicate data entry
  • Support customized trial models for precise research needs
  • Import existing clinical libraries to accelerate study setup
  • Create efficient data entry screens that reduce errors

Operational Impact and Efficiency Gains

Solventum, which manages approximately 45 clinical studies globally, has seen significant improvements in their research operations. Two-thirds of these studies are conducted in healthcare and dental facilities, with one-third performed at their in-house facility focusing on medical and dental products.
The platform's flexibility has proven particularly valuable for Solventum's specialized research needs. "Zelta helps expedite the build process because we can import from previously built studies," Dahling noted. "It worked out pretty slick."

Quality Control and Data Integrity

The system's impact on data quality has been substantial. Solventum measures success through meeting internal timelines and maintaining low preventable error rates. The platform's intuitive interface and real-time error correction capabilities have resulted in more efficient data entry and reduced costs.
"It's a huge benefit and time saver. The methodical flow of the screen makes for very effective data entry," Dahling stated. "Having the ability to correct those data entry errors in real-time saves a lot of time and money."
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Reference News

[1]
Innovating randomization in clinical trials - Pharmaceutical Technology
pharmaceutical-technology.com · Dec 13, 2024

Solventum reduced trial build timelines using Zelta's eClinical platform, randomizing teeth in clinical trials, enhancin...

© Copyright 2025. All Rights Reserved by MedPath